Home > R&D > Overview


Humanwell built its state of art,12,000 square meter R&D center in 2008. We search for true medical innovation. Each year, 5% of annual revenue is earmarked for R&D.

Humanwell created long term partnership with leading research institutes in and outside of China. Notably, the Innovation Centre for Drug Research and Development is established jointly with China Academy of Military Sciences.139 candidates are under development at the moment, including 28 Class I drugs, and 29 Class II and Class III candidates.


  • 139

    Number of candidates

    Under development

  • 8

    Number of INDs

    In clinical trial

  • 5%

    Percentage of annual

    Revenue earmarked for R&D

  • 600+

    Number of R&D staff


  • 42

    Number of R&D

    Staff with Ph. D